IRIS Accounts Production v26.1.10.61 05988036 director 1.11.24 31.10.25 31.10.25 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh059880362024-10-31059880362025-10-31059880362024-11-012025-10-31059880362023-10-31059880362023-11-012024-10-31059880362024-10-3105988036ns15:EnglandWales2024-11-012025-10-3105988036ns14:PoundSterling2024-11-012025-10-3105988036ns10:Director12024-11-012025-10-3105988036ns10:PrivateLimitedCompanyLtd2024-11-012025-10-3105988036ns10:SmallEntities2024-11-012025-10-3105988036ns10:AuditExempt-NoAccountantsReport2024-11-012025-10-3105988036ns10:SmallCompaniesRegimeForDirectorsReport2024-11-012025-10-3105988036ns10:SmallCompaniesRegimeForAccounts2024-11-012025-10-3105988036ns10:FullAccounts2024-11-012025-10-310598803612024-11-012025-10-3105988036ns10:RegisteredOffice2024-11-012025-10-3105988036ns5:CurrentFinancialInstruments2025-10-3105988036ns5:CurrentFinancialInstruments2024-10-3105988036ns5:Non-currentFinancialInstruments2025-10-3105988036ns5:Non-currentFinancialInstruments2024-10-3105988036ns5:ShareCapital2025-10-3105988036ns5:ShareCapital2024-10-3105988036ns5:RetainedEarningsAccumulatedLosses2025-10-3105988036ns5:RetainedEarningsAccumulatedLosses2024-10-3105988036ns5:NetGoodwill2024-11-012025-10-3105988036ns5:IntangibleAssetsOtherThanGoodwill2024-11-012025-10-3105988036ns5:PlantMachinery2024-11-012025-10-3105988036ns5:FurnitureFittings2024-11-012025-10-3105988036ns5:MotorVehicles2024-11-012025-10-3105988036ns5:ComputerEquipment2024-11-012025-10-3105988036ns5:NetGoodwill2024-10-3105988036ns5:NetGoodwill2025-10-3105988036ns5:NetGoodwill2024-10-3105988036ns5:PlantMachinery2024-10-3105988036ns5:FurnitureFittings2024-10-3105988036ns5:MotorVehicles2024-10-3105988036ns5:ComputerEquipment2024-10-3105988036ns5:PlantMachinery2025-10-3105988036ns5:FurnitureFittings2025-10-3105988036ns5:MotorVehicles2025-10-3105988036ns5:ComputerEquipment2025-10-3105988036ns5:PlantMachinery2024-10-3105988036ns5:FurnitureFittings2024-10-3105988036ns5:MotorVehicles2024-10-3105988036ns5:ComputerEquipment2024-10-3105988036ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2024-11-012025-10-3105988036ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2025-10-3105988036ns5:WithinOneYearns5:CurrentFinancialInstruments2025-10-3105988036ns5:WithinOneYearns5:CurrentFinancialInstruments2024-10-31
REGISTERED NUMBER: 05988036 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED

31 OCTOBER 2025

FOR

NEUROPHYSIOPLUS LTD

NEUROPHYSIOPLUS LTD (REGISTERED NUMBER: 05988036)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025










Page

Company information 1

Balance sheet 2

Notes to the financial statements 4


NEUROPHYSIOPLUS LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 OCTOBER 2025







Director: A P Chatham





Registered office: Sandford House
6-7 Lower High Street
Stourbridge
West Midlands
DY8 1TE





Registered number: 05988036 (England and Wales)





Accountants: Athos Business Solutions Limited
1623 Warwick Road
Knowle
Solihull
West Midlands
B93 9LF

NEUROPHYSIOPLUS LTD (REGISTERED NUMBER: 05988036)

BALANCE SHEET
31 OCTOBER 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 67,740 78,160
67,740 78,160

CURRENT ASSETS
Debtors 6 164,022 209,204
Cash at bank and in hand 54,451 13,505
218,473 222,709
CREDITORS
Amounts falling due within one year 7 107,199 97,476
NET CURRENT ASSETS 111,274 125,233
TOTAL ASSETS LESS CURRENT
LIABILITIES

179,014

203,393

CREDITORS
Amounts falling due after more than one
year

8

(31,021

)

(44,962

)

PROVISIONS FOR LIABILITIES (16,935 ) -
NET ASSETS 131,058 158,431

NEUROPHYSIOPLUS LTD (REGISTERED NUMBER: 05988036)

BALANCE SHEET - continued
31 OCTOBER 2025

2025 2024
Notes £    £    £    £   
CAPITAL AND RESERVES
Called up share capital 10 10
Retained earnings 131,048 158,421
131,058 158,431

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 13 July 2026 and were signed by:





A P Chatham - Director


NEUROPHYSIOPLUS LTD (REGISTERED NUMBER: 05988036)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025


1. STATUTORY INFORMATION

Neurophysioplus Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2018, is being amortised evenly over its estimated useful life of five years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Plant and machinery - 20% on reducing balance
Fixtures & Fittings - 20% on reducing balance
Motor vehicles - 20% on reducing balance
Computer equipment - 20% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


NEUROPHYSIOPLUS LTD (REGISTERED NUMBER: 05988036)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 OCTOBER 2025


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 12 (2024 - 11 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
Cost
At 1 November 2024
and 31 October 2025 16,000
Amortisation
At 1 November 2024
and 31 October 2025 16,000
Net book value
At 31 October 2025 -
At 31 October 2024 -

NEUROPHYSIOPLUS LTD (REGISTERED NUMBER: 05988036)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 OCTOBER 2025


5. TANGIBLE FIXED ASSETS
Plant and Fixtures Motor Computer
machinery & Fittings vehicles equipment Totals
£    £    £    £    £   
Cost
At 1 November 2024 40,886 32,453 56,383 31,263 160,985
Additions 3,950 - - 1,688 5,638
Reclassification/transfer - - (1 ) - (1 )
At 31 October 2025 44,836 32,453 56,382 32,951 166,622
Depreciation
At 1 November 2024 23,729 23,063 9,296 26,737 82,825
Charge for year 3,827 1,878 9,418 934 16,057
At 31 October 2025 27,556 24,941 18,714 27,671 98,882
Net book value
At 31 October 2025 17,280 7,512 37,668 5,280 67,740
At 31 October 2024 17,157 9,390 47,087 4,526 78,160

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:
Motor
vehicles
£   
Cost
Reclassification/transfer 51,084
At 31 October 2025 51,084
Depreciation
Charge for year 9,196
Reclassification/transfer 5,108
At 31 October 2025 14,304
Net book value
At 31 October 2025 36,780

NEUROPHYSIOPLUS LTD (REGISTERED NUMBER: 05988036)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 OCTOBER 2025


6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 56,289 95,753
Other debtors 107,733 113,451
164,022 209,204

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts 5,833 10,000
Hire purchase contracts 8,107 8,107
Trade creditors - 4,944
Taxation and social security 56,879 35,862
Other creditors 36,380 38,563
107,199 97,476

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2025 2024
£    £   
Bank loans - 5,833
Hire purchase contracts 31,021 39,129
31,021 44,962

9. FINANCIAL COMMITMENTS, GUARANTEES AND CONTINGENCIES

A cross-company guarantee is given whereby on receipt of a demand in writing the liabilities in respect of
bank loans in this company and its parent company will be discharged by the company not otherwise in
default.